ATE375404T1 - Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose - Google Patents

Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose

Info

Publication number
ATE375404T1
ATE375404T1 AT01114412T AT01114412T ATE375404T1 AT E375404 T1 ATE375404 T1 AT E375404T1 AT 01114412 T AT01114412 T AT 01114412T AT 01114412 T AT01114412 T AT 01114412T AT E375404 T1 ATE375404 T1 AT E375404T1
Authority
AT
Austria
Prior art keywords
tumor
markers
blood
relative
presymptomatic
Prior art date
Application number
AT01114412T
Other languages
English (en)
Inventor
Lan Kluwe
Original Assignee
Von Recklinghausen Ges E V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Von Recklinghausen Ges E V filed Critical Von Recklinghausen Ges E V
Application granted granted Critical
Publication of ATE375404T1 publication Critical patent/ATE375404T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01114412T 2000-06-27 2001-06-15 Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose ATE375404T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113607 2000-06-27

Publications (1)

Publication Number Publication Date
ATE375404T1 true ATE375404T1 (de) 2007-10-15

Family

ID=8169084

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01114412T ATE375404T1 (de) 2000-06-27 2001-06-15 Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose

Country Status (4)

Country Link
US (3) US6660477B2 (de)
AT (1) ATE375404T1 (de)
DE (1) DE50113102D1 (de)
ES (1) ES2291246T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2009149166A2 (en) * 2008-06-03 2009-12-10 Children's Hospital Medical Center Methods and compositions for the diagnosis and treatment of proliferative disorders
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
DE102013221452B3 (de) * 2013-10-22 2015-02-26 Universitätsklinikum Hamburg-Eppendorf Verfahren zur Bestimmung der Wirksamkeit und/oder Spezifität eines Wirkstoffs
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
CN111373050A (zh) 2017-06-20 2020-07-03 生物辐射实验室股份有限公司 用于遗传不稳定性的数字扩增试验

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605799A (en) 1990-07-12 1997-02-25 University Of Utah Research Foundation Somatic mutations in neurofibromatosis type 1 gene in human tumors
US5707863A (en) * 1993-02-25 1998-01-13 General Hospital Corporation Tumor suppressor gene merlin
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
AU685627B2 (en) * 1994-03-18 1998-01-22 Myriad Genetics, Inc. Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
US5945522A (en) * 1997-12-22 1999-08-31 Genset Prostate cancer gene

Also Published As

Publication number Publication date
US20040091927A1 (en) 2004-05-13
ES2291246T3 (es) 2008-03-01
DE50113102D1 (de) 2007-11-22
US20110008773A1 (en) 2011-01-13
US6660477B2 (en) 2003-12-09
US20010055770A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
Garcia et al. Effect of environmental factors on PCR-DNA analysis from dental pulp
Sweet et al. PCR-based DNA typing of saliva stains recovered from human skin
ATE312946T1 (de) Verfahren und vorrichtung zur bestimmung der gewebespezifität von freier dna in körperflüssigkeiten
DE50113102D1 (de) Verfahren zur Ermittlung von Daten zur präsymptomatischen oder pränatalen Diagnose von Typ 1 Neurofibromatose
WO2004075733A3 (en) Construction of a deafness gene chip
JP2022517456A5 (de)
DE69828392D1 (de) Verfahren zur Herstellung eines diagnostischen Standard-Gentranskriptionsmusters
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
EP1813684A3 (de) Unterschiedlich exprimierte Gene in gesunden und kranken Individuen
RU99116979A (ru) Масштабное генотипирование заболеваний и диагностический тест на мозжечковую атаксию тип 6
EP1441301A3 (de) Verfahren für das Identifizieren und das Kommunizieren mit möglichen Teilnehmern an klinischen Versuchen
WO2002090583A3 (en) Skin treatment
Nakanishi et al. Effects of environmental conditions to which nails are exposed on DNA analysis of them
Biehler-Gomez et al. Frequency of biological non-skeletal materials in dry bone scenarios
Haglund et al. Identification of decomposed human remains by deoxyribonucleic acid (DNA) profiling
ATE286253T1 (de) Methoden zur diagnose oder prognose der alzheimerschen krankheit
KR102313460B1 (ko) 알츠하이머병 치매의 발병 위험성 예측을 위한 후성 유전학적 진단 키트 개발
KR102139315B1 (ko) Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커
KR102313459B1 (ko) 알츠하이머병 치매 특이적 dna 메틸레이션 마커 검출용 조성물 및 검출방법
JP2022087075A (ja) アトピー性皮膚炎の症度変化の検出方法
Tomsia et al. Human costal cartilage, tooth cavities, and femur nutrient canals—new niches for insects used in forensic entomology
CN114317783B (zh) 龋齿标志微生物及其应用
WO2022186519A1 (ko) 호기 응축물 시료를 이용한 세균 메타게놈 분석 방법
KR102139314B1 (ko) 유전자의 후성학적 메틸화 변화를 이용한 알츠하이머병 치매의 조기 진단 및 예측
JP6288758B2 (ja) 唾液の細菌叢の解析方法